STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of clinical AI.
In July, federal health officials convened private sector representatives and lobbyists for confidential discussions aimed at promoting responsible deployment of clinical artificial intelligence in healthcare. At a "clinical AI demo day" held at the Food and Drug Administration's White Oak facility, representatives from the FDA and the Centers for Medicare and Medicaid Services convened leaders from ten organizations to demonstrate current AI-driven medical solutions.
The meeting served as an opportunity for the companies, ranging from well-established tech behemoths to venture-backed startups, to share their perspectives and guidance with the federal regulators. Attendees included Anthropic, Counsel Health, Curai, K Health, Microsoft AI, Amazon's One Medical, Doctronic, Ellipsis Health, Hippocratic AI, and Welldoc.
Four of these companies, Counsel Health, K Health, Hippocratic AI, and Ellipsis Health, shared their feedback with STAT. The gathering aimed to facilitate a dialogue between the tech industry and health authorities as they grapple with the regulation and reimbursement of AI-powered diagnostic and therapeutic tools in the medical landscape.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
